JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 51 filers reported holding JANUX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,196 | -6.0% | 20,456 | +10.7% | 0.00% | – |
| Q2 2023 | $219,368 | -45.9% | 18,481 | -44.8% | 0.00% | – |
| Q1 2023 | $405,399 | +76.1% | 33,504 | +91.6% | 0.00% | – |
| Q4 2022 | $230,264 | -88.0% | 17,484 | -87.6% | 0.00% | – |
| Q3 2022 | $1,916,000 | +468.5% | 141,480 | +410.2% | 0.00% | – |
| Q2 2022 | $337,000 | -15.3% | 27,733 | -0.0% | 0.00% | – |
| Q1 2022 | $398,000 | +39.6% | 27,743 | +91.6% | 0.00% | – |
| Q4 2021 | $285,000 | +96.6% | 14,479 | +116.0% | 0.00% | – |
| Q3 2021 | $145,000 | +7150.0% | 6,702 | +6602.0% | 0.00% | – |
| Q2 2021 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |